Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MONTELUKAST SODIUM
- Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers
- Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers
- Study on the Correlation Between Intestinal Microecology and Allergic Diseases in Children
- Evaluation of the Effectiveness of Montelukast in Children With Recurrent Obstructive Bronchitis
- Role of Montelukast in Modulation of Response to Sepsis in Preterm Infants
- Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children
- Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
- Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions
- Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough
- Comparison of the Effects of Nasal Steroids and Montelukast on Olfactory Functions in Patients With Allergic Rhinitis
- Preoperative Use of Montelukast Sodium
- Montelukast for Postinfectious Cough
- Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects
- Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute Cough
- Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable 5mg Tablet Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable Tablets 5mg Under Fasted Conditions
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fed Conditions
- Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium 10mg Tablet Under Fasted Conditions
- Study of the Efficacy and Safety of MK-0476 in Japanese Pediatric Participants With Seasonal Allergic Rhinitis (MK-0476-519)
- The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
- Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fed Condition
- Bioequivalence Study of Montelukast Sodium Oral Granules 4mg Under Fasting Condition
- Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fed Condition
- Bioequivalence Study of Montelukast Sodium Chewable Tablets 4mg and 5mg Under Fasting Condition
- Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fed Condition
- Bioequivalence Study of Montelukast Sodium Tablets 10mg Under Fasting Condition
- Bioequivalency Study of Montelukast 10 mg Tablets Under Fasted Conditions
- Bioequivalency Study of Montelukast 10 mg Tablets Under Fed Conditions
- Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fasted Conditions
- Bioequivalency Study of Montelukast Chewable 5 mg Tablets Under Fed Conditions
- Efficacy and Safety of Concomitant Montelukast Sodium and Levocetirizine Dihydrochloride in Perennial Allergic Rhinitis (PAR) Patients
- A Drug Interaction Study of Montelukast and Levocetirizine
- Safety and Efficacy of YHD001 in Asthma
- Targeted Therapy of Bronchiolitis Obliterans Syndrome
- Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)
- Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)
- Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
- A Study Comparing Montelukast With Placebo in Children With Seasonal Allergic Rhinitis (0476-219)(COMPLETED)
- Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)
- Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma
- A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)
- Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)
- Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)
- The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
- Trial of Montelukast for Treatment of Acute Bronchiolitis
- Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)
- MK0476 Study in Adult Patients With Perennial Allergic Rhinitis (0476-397)(COMPLETED)
- Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)
- The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)
- Effects of Montelukast in Children With Asthma
- Exercise Induced Bronchoconstriction (0476-359)
- Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children
- Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal Allergen
- Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposu
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
- Singulair(R) In Asthma And Allergic Rhinitis (0476-383)
- A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
- Pharmacological Modulations of Allergen-Specific Immunotherapy
- Comparison of the Effect of Montelukast and Cetirizine on Allergic Inflammation in Children With Allergic Rhinitis
- Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma
- Montelukast in Mild Asthmatic Children With Allergic Rhinitis (0476-367)
- Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)
- Does Montelukast Have an Affect on the Function of the Artery in Patients With Heart Disease
- Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)
- Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
- Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
- Pediatric Asthma Controller Trial (PACT)
- MK0476 Study in Adult Patients With Acute Asthma (0476-322)
- A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease
- A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)
- A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
- A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
- An Approved Drug to Study a New Indication for Allergic Rhinitis (0476-327)
- Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
- A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab
- A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)
- Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
- Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
- An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
- Asthma Clinical Research Network (ACRN)
Clinical trials list
click for details